These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36855900)

  • 1. Thyroid eye disease in Eastern Province of Saudi Arabia: clinical profile and correlation with vitamin D deficiency.
    Alali M; Alkulaib NS; Alkhars A; Albadri K; Al Hassan S; Elewa M; Aldairi W; Alsaqer SK; Al-Abdulqader RA; Alhammad F
    Orbit; 2024 Feb; 43(1):28-32. PubMed ID: 36855900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Vitamin D Deficiency Is an Independent Risk Factor for Thyroid Eye Disease.
    Heisel CJ; Riddering AL; Andrews CA; Kahana A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):17-20. PubMed ID: 31568022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation?
    Ramamurthy LB; Rangarajan V; Srirao N; Malini B; Bansal R; Yuvarajan K
    Indian J Ophthalmol; 2020 Jun; 68(6):1127-1131. PubMed ID: 32461446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients in a combined thyroid eye clinic in secondary care.
    Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
    Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis.
    Oeverhaus M; Winkler L; Stähr K; Daser A; Bechrakis N; Stöhr M; Chen Y; Eckstein A
    Front Endocrinol (Lausanne); 2023; 14():1160172. PubMed ID: 37082130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypo vs. hyperthyroid eye disease: is there any difference?
    Eshraghi B; Pourazizi M; Abbasi M; Mohammadbeigy I
    BMC Ophthalmol; 2023 Feb; 23(1):58. PubMed ID: 36765316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Other Autoimmune Diseases With Thyroid Eye Disease.
    Kelada M; Avari P; Farag S; Akishar R; Jain R; Aziz A; Feeney C; Bravis V; Meeran K; Lee V
    Front Endocrinol (Lausanne); 2021; 12():644200. PubMed ID: 33746907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral versus unilateral thyroid eye disease.
    Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
    Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of thyroid eye disease and factors predictive of disease severity.
    Muralidhar A; Das S; Tiple S
    Indian J Ophthalmol; 2020 Aug; 68(8):1629-1634. PubMed ID: 32709794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
    Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
    Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia.
    Hussain AN; Alkhenizan AH; El Shaker M; Raef H; Gabr A
    Arch Osteoporos; 2014; 9():190. PubMed ID: 25213798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of development of dysthyroid optic neuropathy among individuals with thyroid-eye disease.
    Kemchoknatee P; Thongsawangchai N; Srisombut T; Tangon D; Chantra S
    Eur J Ophthalmol; 2024 May; 34(3):834-842. PubMed ID: 37661652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors of Thyroid Eye Disease.
    Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
    Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
    Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D
    Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis.
    Patel VK; Padnick-Silver L; D'Souza S; Bhattacharya RK; Francis-Sedlak M; Holt RJ
    Endocr Pract; 2022 Feb; 28(2):159-164. PubMed ID: 34781042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial Keratitis in Thyroid Eye Disease: Clinical Features, Microbiological Profile, and Treatment Outcome.
    Naik MN; Vasanthapuram VH; Joseph J; Murthy SI
    Ophthalmic Plast Reconstr Surg; 2019; 35(6):543-548. PubMed ID: 30844912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.
    Quinn AS; Dujardin LR; Knight B; Benzimra J; Quinn AG; Vaidya B
    Int Ophthalmol; 2018 Feb; 38(1):301-306. PubMed ID: 28181061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.